title: Use of extracorporeal membrane oxygenation for mechanical circulatory support in a patient with 5-fluorouracil induced acute heart failure.
authors.affiliation: From the John McCarthy Intensive Care Unit (S.R., K.S., B.B.), Critical Care Research Group (K.S., B.B.), and Department of Cardiothoracic Surgery, Heart Lung Institute (R.N.), Prince Charles Hospital, Brisbane, Australia; University of Queensland, Brisbane, Australia (K.S., B.B.); and Department of Hematology, Redcliffe Hospital, Brisbane, Australia (D.M.).
authors.forename: Shruti
authors.initials: S
authors.lastname: Rateesh
authors.affiliation: From the John McCarthy Intensive Care Unit (S.R., K.S., B.B.), Critical Care Research Group (K.S., B.B.), and Department of Cardiothoracic Surgery, Heart Lung Institute (R.N.), Prince Charles Hospital, Brisbane, Australia; University of Queensland, Brisbane, Australia (K.S., B.B.); and Department of Hematology, Redcliffe Hospital, Brisbane, Australia (D.M.).
authors.forename: Kiran
authors.initials: K
authors.lastname: Shekar
authors.affiliation: From the John McCarthy Intensive Care Unit (S.R., K.S., B.B.), Critical Care Research Group (K.S., B.B.), and Department of Cardiothoracic Surgery, Heart Lung Institute (R.N.), Prince Charles Hospital, Brisbane, Australia; University of Queensland, Brisbane, Australia (K.S., B.B.); and Department of Hematology, Redcliffe Hospital, Brisbane, Australia (D.M.).
authors.forename: Rishendran
authors.initials: R
authors.lastname: Naidoo
authors.affiliation: From the John McCarthy Intensive Care Unit (S.R., K.S., B.B.), Critical Care Research Group (K.S., B.B.), and Department of Cardiothoracic Surgery, Heart Lung Institute (R.N.), Prince Charles Hospital, Brisbane, Australia; University of Queensland, Brisbane, Australia (K.S., B.B.); and Department of Hematology, Redcliffe Hospital, Brisbane, Australia (D.M.).
authors.forename: Dolly
authors.initials: D
authors.lastname: Mittal
authors.affiliation: From the John McCarthy Intensive Care Unit (S.R., K.S., B.B.), Critical Care Research Group (K.S., B.B.), and Department of Cardiothoracic Surgery, Heart Lung Institute (R.N.), Prince Charles Hospital, Brisbane, Australia; University of Queensland, Brisbane, Australia (K.S., B.B.); and Department of Hematology, Redcliffe Hospital, Brisbane, Australia (D.M.). balu.bhaskar@health.qld.gov.au.
authors.forename: Balu
authors.initials: B
authors.lastname: Bhaskar
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy; D000328:Adult; D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects*; D066126:Cardiotoxicity / Q000209:etiology; D015179:Colorectal Neoplasms / Q000188:drug therapy; D015199:Extracorporeal Membrane Oxygenation; D005472:Fluorouracil / Q000009:adverse effects*; D006333:Heart Failure / Q000139:chemically induced*; D006801:Humans; D007423:Intra-Aortic Balloon Pumping; D008297:Male; D009205:Myocarditis / Q000139:chemically induced; D012770:Shock, Cardiogenic / Q000139:chemically induced
chemical_list: D000964:Antimetabolites, Antineoplastic; D005472:Fluorouracil
keywords: acute heart failure; drug-related side effects and adverse reactions; extracorporeal life support; extracorporeal membrane oxygenation support; shock, cardiogenic